Gian Luca Di Tanna

Effect of Salt Substitution on Cardiovascular Events and Death

Bruce Neal, Yangfeng Wu, Xiangxian Feng et al. · New England Journal of Medicine · 2021 · 669 citations · Full text

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

Tjeerd van Staa, Efrosini Setakis, Gian Luca Di Tanna et al. · Journal of Thrombosis and Haemostasis · 2010 · 272 citations · Full text

Thrombosis, Cardiovascular Epidemiology, Cardiovascular Disease +15

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour et al. · The Lancet Diabetes & Endocrinology · 2020 · 262 citations · Full text

Renal Function, Renal Disease, Crossover Trial +7

Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey

Carla Felice, Gian Luca Di Tanna, Giacomo Zanus et al. · Journal of Community Health · 2020 · 184 citations · Full text

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

Meg Jardine, Zien Zhou, Kenneth W. Mahaffey et al. · Journal of the American Society of Nephrology · 2020 · 172 citations · Full text